Helminthic therapy and women's health
Adenomyosis[edit | edit source]
See also
Breast and ovarian cancers[edit | edit source]
See Helminthic therapy and cancer
Endometriosis[edit | edit source]
The scientific evidence
There are no known scientific studies on the effect of helminths on endometriosis. Helminths may act on the underlying causes: inflammation and dysbiosis. (See Helminthic therapy research)
See also
- 2026 Apr 15 CX3CR1/P2X4R signaling-mediated spinal microglial M1 polarization contributes to chronic pelvic pain in endometriosis
- 2026 Feb 26 Endometriosis immune microenvironment timing shifts: from immune escape to immune exhaustio (Online ahead of print)
- 2026 Feb 5 Neutrophil extracellular traps in gynecological disease: pathogenic mechanisms and therapeutic opportunities
- 2026 Jan 8 Eutopic Endometrium Immune Changes Involved in Development and Progression of Endometriosis: A Review
- 2025 Dec 18 Endometriosis as an immune-mediated disease: pathogenetic mechanisms and therapeutic strategies
- 2025 Dec 9 Regulatory T-cells in Reproductive Medicine: Implications for Endometriosis-Associated Infertility and Implantation Immunity
- 2025 Dec Targeting inflammation in endometriosis: emerging therapeutic options
- 2025 Nov 7 Evaluation of microecological therapy in endometriosis through modulation of the gut microbiota
- 2025 Nov An investigation of the IL-23/Th17 axis and transcriptomic profiles of Th1, Th1/17, and Th17 cells in endometriosis patients as compared to controls (Conference)
- 2025 Nov Inflammatory Cytokine Signatures Are Associated With Disease Burden and Comorbidity of Episodic Migraine and Endometriosis
- 2025 Nov Reframing Endometriosis: Interplay of NETs, Macrophages, and Lymphocytes at the Crossroads of Disease Progression, Infertility, and Malignant Transformation
- 2025 Oct 21 Macrophages in endometriosis: key roles and emerging therapeutic opportunities-a narrative review
- 2025 Sep 5 Dysfunction of natural killer cells promotes immune escape and disease progression in endometriosis
- 2025 Jun Increased circulating T helper 17 (TH17) cells and endometrial tissue IL-17-producing cells in patients with endometriosis compared with non-endometriotic subjects
- 2025 May 28 Endometriosis: An Immunologist's Perspective
- 2025 May 1 Adoptive transfer of regulatory T cells inhibits the progression of endometriosis-like lesions in regulatory T-cell-depleted mice
- 2025 Mar Immunopathology of Endometriosis, Molecular Approaches
- 2025 Feb 19 Exploring macrophage and nerve interaction in endometriosis-associated pain: the inductive role of IL-33
- 2024 Nov 7 Infertility, IL-17, IL-33 and Microbiome Cross-Talk: The Extended ARIA-MeDALL Hypothesis
- 2024 Sep Growing evidence that endometriosis is a systemic disease
- 2024 May 22 Foxp3+CD39+CD73+ regulatory T-cells are decreased in the peripheral blood of women with deep infiltrating endometriosis
- 2025 May 16 Role of neutrophils in the immune microenvironment of endometriosis
- 2024 Dec The role and potential treatment of macrophages in patients with infertility and endometriosis
- 2024 May 16 The role of regulatory T-cells in the development of endometriosis
- 2024 Feb 16 Unraveling the microbial puzzle: exploring the intricate role of gut microbiota in endometriosis pathogenesis
- 2023 Jan 5 IL-10 is not anti-fibrotic but pro-fibrotic in endometriosis: IL-10 treatment of endometriotic stromal cells in vitro promotes myofibroblast proliferation and collagen type I protein expression
- 2022 May Immunopathogenesis of endometriosis: An overview of the role of innate and adaptive immune cells and their mediators
- 2019 Jun Anti-inflammatory cytokines in endometriosis
Gut Microbiota Dysbiosis
- 2026 Feb 2 Modulation of gut microbiota and short-chain fatty acids by probiotics attenuates inflammation in endometriosis
- 2026 Jan 30 Gut microbiota as a key regulator in endometriosis: mechanisms, therapeutic opportunities, and future perspectives
- 2026 Jan 23 Gut microbiota composition and systemic immune-inflammatory marker correlations in infertile women with endometriosis: a pilot case-control study
- 2025 Dec 5 Microbiota insights in endometriosis
- 2025 Nov Research progress on the correlation between microbiota and endometriosis
- 2025 Nov The Role of the Microbiome in Endometriosis
- 2025 Sep 16 Leveraging the role of the microbiome in endometriosis: novel non-invasive and therapeutic approaches
- 2025 Jul 7 Impact of gut microbiota on endometriosis: linking physical injury to mental health
- 2025 May 27 Gut Microbiota Dysbiosis in Endometriosis: A Potential Link to Inflammation and Disease Progression
- 2024 Mar 5 Role of the gut microbiota in the pathogenesis of endometriosis: a review
The anecdotal evidence
Fertility[edit | edit source]
See Helminthic therapy and fertility
Fibromyalgia[edit | edit source]
See Helminthic therapy and fibromyalgia
Menstruation[edit | edit source]
The physiological and immunological changes produced by helminths can affect fertility [5] so it should perhaps be no surprise that they can also influence menstruation, especially since they have a powerful anti-inflammatory effect.
Period pain (Dysmenorrhoea / dysmenorrhea)[edit | edit source]
Menstruation, irregular[edit | edit source]
Period timing[edit | edit source]
Another hookworm host has mentioned that, on two occasions, her period came early (at 3 weeks) after doses of hookworms.
Premenstrual syndrome (PMS)[edit | edit source]
Premenstrual syndrome is arguably an inflammatory condition.
Helminths are powerful anti-inflammatory agents. [16]
PMS is not only a problem in its own right, but may indicate a greater risk of developing other diseases later in life, which helminths may also help to prevent.
The anecdotal evidence
Pelvic inflammatory disease (PID)[edit | edit source]
Pelvic inflammatory disease is most often caused by sexually‑transmitted bacteria such as Neisseria gonorrhoeae and Chlamydia trachomatis. However, the human pinworm, Enterobius vermicularis (EV) can also, rarely, be a contributor to pelvic‑tract inflammation that can mimic or precipitate PID, which is one of several reasons why this particular organism is not used in helminthic therapy. See Enterobius vermicularis.
Polycystic ovary syndrome (PCOS)[edit | edit source]
See also
- 2026 Jan 20 The interactions between autophagy and immune in the liver-adipose-ovary circuit of polycystic ovary syndrome
- 2025 Mar 18 Unraveling the gut microbiota's role in PCOS: a new frontier in metabolic health
- 2024 Dec Unveiling the complex interplay between gut microbiota and polycystic ovary syndrome: A narrative review
- 2024 May 30 Balancing Act: Exploring the Gut Microbiota-Brown Adipose Tissue Axis in PCOS Pathogenesis and Therapeutic Frontiers
- 2024 Feb White-brown adipose tissue interplay in polycystic ovary syndrome: Therapeutic avenues
- 2021 Oct Gut microbiota as the critical correlation of polycystic ovary syndrome and type 2 diabetes mellitus
- 2019 Mar 26 Evolutionary origins of polycystic ovary syndrome: An environmental mismatch disorder
Pregnancy[edit | edit source]
See Helminthic therapy and pregnancy